The following is an excerpt from Becker’s Hospital Review. Some hospital leaders are optimistic that artificial intelligence could liberate their clinicians from hours of administrative work and return them to the bedside. “These new generative AI tools, the large language […]
Can AI save hospitals from the staffing crisis? Read More »
The following is an excerpt from The Vaccine Reaction. On Jan. 13 2023, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for U.S. Disease Control and Prevention (CDC)) issued a public statement regarding the identification of a
The following is from an article featured in The BMJ by Peter Doshi, senior editor at The BMJ and an associate professor of pharmaceutical health services research at the University of Maryland School of Pharmacy. Doshi shares the story of how
BMJ investigation into ‘revolving door culture’ between the FDA and Big Pharma Read More »
Nearly a quarter of Americans believe someone they know died from Covid-19 vaccine side effects, and even more say they might be willing to become plaintiffs in a class-action lawsuit against vaccine makers. That’s according to the latest Rasmussen Reports.
(POLL) 24% say someone they know died from Covid-19 vaccine Read More »
A shortage of chemotherapy medicine used to treat cancer patients is forcing doctors to make rationing choices, cutting back on how much is used, and deciding which patients do or don’t get it. Lisa Fletcher reports on what’s behind the
Ninety-three percent (93%) of those polled say they aren’t worried about Covid. That’s according to the latest unscientific poll of 1,052 people at SharylAttkisson.com. The unworried include 56% who say they aren’t very concerned and 37% who replied to the
News reports indicate that Dan Ziegler, a Washington lobbyist counting among his clients PhRMA, Pfizer, Merck, Sanofi, Eli Lilly and Amgen, will join House Speaker Mike Johnson’s office as policy director. Public Citizen, a nonprofit consumer advocacy organization that works
(READ) New House Speaker Mike Johnson hires Pharma lobbyist to join his staff Read More »
The following is from an article published in MDPI – Publisher of Peer Reviewed Open Access Journals. A new study illustrates that the onset of debilitating symptoms following SARS-CoV-2 vaccination is thought to constitute a new, novel disease entity, for
(STUDY) New study identifies ‘post-acute Covid 19 vaccination syndrome’ Read More »
